Navigation Links
Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference

RALEIGH, N.C., Feb. 19 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that executives from its Brand Management and Managed Markets practices will present at the 4th Annual Forum on Early Stage Product Development and Commercialization Strategies for the Bio/Pharmaceutical Industry hosted by the Center for Business Intelligence (CBI). The conference will be held February 25-26, 2008, at the Doubletree Hotel in Philadelphia, Pennsylvania.

Tom Luginbill, Vice President, and Philip Vorhies, Practice Executive, of the firm's Brand Management practice will present a workshop titled "Comprehensive Commercial Planning for Product Launch" at 3:30 pm on February 25. They will provide a comprehensive understanding of each stage of pre- launch commercial planning and identify the key deliverables for each stage. They will also discuss strategies for managing the logistics of a launch. In addition, the workshop will feature an interactive working session, during which delegates will collaborate to determine the timing of each commercial planning stage and logistics-related activity during this critical phase of a product's life cycle.

Tom Luginbill currently leads the Brand Management practice's Central region operations, but he has spent the majority of his career in the industry. In the course of his 20-year career, he has had a wide variety of commercial roles, including Sales Representative, Marketing Director, and Regional Sales Director. He also served as the Vice President of Commercial Strategy at GlaxoSmithKline, where he was responsible for the worldwide commercial development of the company's antibiotic portfolio.

Philip Vorhies brings years of experience in the pharmaceutical industry and management consulting to his work with Campbell Alliance. Mr. Vorhies has in-depth experience with launch management, life cycle planning, and commercial strategy development in multiple therapeutic areas, with specific expertise in the senior care environment.

On the second day of the conference, Kevin Barnett, Senior Vice President, will present a session titled "Early Considerations for Building Your Product's Value Proposition for Payers" at 10:15 am. Mr. Barnett's session will discuss how to apply a strategic framework for developing a payer value proposition in a rapidly evolving reimbursement environment.

As head of the firm's Managed Markets practice, Mr. Barnett is an expert at developing successful strategies that address access, pricing, marketing, and policy concerns for many of the world's leading pharmaceutical and biotech companies. During the span of his career, he has held positions at two management consulting firms as well as various commercial roles at The Upjohn Company. In recent years, Mr. Barnett has been working closely with companies to help understand and prepare for the implications of the Medicare Modernization Act.

For more information on CBI's Forum on Early Stage Product Development and Commercialization Strategies, please visit

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at

About the Brand Management Practice at Campbell Alliance

The Brand Management practice at Campbell Alliance can help enhance the commercial performance of products from initial launch through product maturity. The firm's team members are experts at new product planning, commercial strategy development, brand planning, product launch, and myriad other aspects of maximizing the value of pharmaceutical assets. The team has also developed commercial strategies and programs in various geographic markets, including the US, Canada, Europe, and Latin America. Services include

-- Portfolio planning

-- New product planning

-- Launch excellence

-- Growth maximization

-- Life cycle extension

-- Capability enhancement

About the Managed Markets Practice at Campbell Alliance

The Managed Markets practice at Campbell Alliance helps clients stay informed about changing conditions affecting the reimbursement and access landscape, understand the implications of these trends, and deal more effectively with third-party payers. Services include

-- Market assessments utilizing quantitative and qualitative research and

analysis as well as decision-support modeling and scenario planning

-- Strategy development for key managed markets channels such as the

creation of value propositions and pricing and contracting strategies

-- Tactical execution including account segmentation and prioritization

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit


James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
2. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
3. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Named Best Place to Work by Triangle Business Journal
6. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
7. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
8. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
9. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
10. HOYA ConBio and The Hornbrook Group Announce Expanded Alliance
11. Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):